The Queensland / Brisbane Market
Queensland's Pharmaceuticals & Life Sciences market — centered in Brisbane, with the 2032 Olympics driving significant technology infrastructure investment — operates under federal Australian frameworks and Queensland's Information Privacy Act 2009, which creates specific requirements for Queensland Government agencies and their technology suppliers. The Queensland Health ecosystem and the state's energy transition infrastructure create sector-specific technology mandates.
Pharmaceuticals & Life Sciences organizations in Queensland operate under both federal OAIC oversight and the Queensland Information Commissioner's jurisdiction — separate enforcement regimes with some overlap and some divergence. Engineering teams serving Queensland need both mapped. We deploy with Queensland-specific compliance architecture built in, not assumed equivalent to the federal framework.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Queensland / Brisbane is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Queensland / Brisbane. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Queensland / Brisbane. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Queensland / Brisbane. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.